Pargyline is a potent, irreversible monoamine oxidase type B (MAO-B) inhibitor utilized clinically as an adjunctive therapy for Parkinson's disease, where it functions by preventing the breakdown of neurotransmitters… Read more
Pargyline is a potent, irreversible monoamine oxidase type B (MAO-B) inhibitor utilized clinically as an adjunctive therapy for Parkinson's disease, where it functions by preventing the breakdown of neurotransmitters like dopamine and norepinephrine. To ensure the safety and efficacy of pharmaceutical formulations, laboratories rely on high-quality reference standards of Pargyline Hydrochloride and its related compounds. This collection provides essential materials for rigorous analytical testing, including the identification and quantification of process-related impurities and degradation products during impurity profiling. Additionally, stable isotope labelled compounds are available to serve as internal standards for mass spectrometry-based assays, facilitating precise method validation and quality control procedures. By utilizing these certified reference materials, researchers can accurately assess drug stability and ensure compliance with regulatory standards throughout the pharmaceutical development lifecycle.